T. Rowe Price Associates
Asset Manager / CrossoverBaltimore, USASee on the maptroweprice.com
T. Rowe Price is a global investment management firm that actively manages investments across equity, fixed income, multi-asset, and alternative asset classes.
- 2
- Portfolio companies on reccy
- 1
- Hiring now
- 21
- Open roles in the portfolio
- Sep 2025
- Latest portfolio round
Hiring now in the portfolio21
Apply on each company's site- Posted 17d ago
Financial Accountant
Saluda Medical · Minnetonka, Minnesota
- Posted 19d ago
Manager Clinical Affairs
Saluda Medical · US
- Posted 1mo ago
Design Assurance Engineer
Saluda Medical · Minnetonka, Minnesota
- Posted 1mo ago
Principal Quality Design Assurance Engineer
Saluda Medical · Macquarie Park, New South Wales
- Posted 2mo ago
Territory Manager - Atlanta (South) / Central, GA
Saluda Medical · Atlanta, GA
- Posted 2mo ago
Clinical Specialist - Philadelphia, PA
Saluda Medical · Philadelphia, PA
- Posted 2mo ago
Clinical Specialist - Santa Rosa, CA
Saluda Medical · Santa Rosa, CA
- Posted 2mo ago
Clinical Specialist - Louisville, KY
Saluda Medical · Louisville, KY
Portfolio on reccy2
From company funding recordsTheir companies, round by round
From company funding records- Saluda MedicalBloomington, Minnesota
- Dec 2025IPO · $150M
- Jan 2025Venture Round · $100M
- Apr 2023Venture Round · $150M
- Mar 2022Venture Round · $125MLed
- UndatedFunding Round
- UndatedVenture Round
- Galvanize Therapeutics, Inc.Redwood City, CA
- Nov 2026Series D · $130M
- Sep 2025Series C · $100MLed
- Sep 2022Series B · $100M
- Mar 2022Debt · $4M
- Mar 2022Series A · $3.4M
- Mar 2022Debt · $2M
Rounds marked Led list T. Rowe Price Associates as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Sep 2025
Galvanize Therapeutics, Inc. · Series C $100MLead
With Sofinnova Partners, Norwest Venture Partners, Elevage Medical Technologies, Ally Bridge Group, Perceptive Xontogeny Venture Fund, Janus Henderson Investors, Longaeva, Fidelity Management & Research Company, Gilmartin Capital, Apple Tree Partners
- Mar 2022
Saluda Medical · Venture Round $125MLead
Portfolio in the news
From the Cortex · last 12 months- Nov 2026Saluda Medical at Bell Potter Healthcare Conference: growth, but cash burn remains
Saluda Medical · Investing.com Australia
- Nov 2026
- Oct 2026